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The clinical presentation of gastroesophageal reflux disease (GERD) shows a
large symptom variation also in different intensities among patients. As several
studies have shown, there is a large overlap in the symptomatic spectrum
between proven GERD and other disorders such as dyspepsia, functional
heartburn and/or somatoform disorders.
AIM
To prospectively evaluate the GERD patients with and without somatoform
disorders before and after laparoscopic antireflux surgery.
METHODS
In a tertiary referral center for foregut surgery over a period of 3 years patients
with GERD, qualifying for the indication of laparoscopic antireflux surgery, were
investigated prospectively regarding their symptomatic spectrum in order to
identify GERD and associated somatoform disorders. Assessment of symptoms
was performed by an instrument for the evaluation of somatoform disorders
[Somatoform Symptom Index (SSI) > 17]. Quality of life was evaluated by
Gastrointestinal Quality of Life Index (GIQLI).
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RESULTS
In 123 patients an indication for laparoscopic antireflux surgery was established
and in 43 patients further medical therapy was suggested. The portion of
somatoform tendencies in the total patient population was 20.48% (34 patients).
Patients with a positive SSI had a preoperative GIQLI of 77 (32-111). Patients with
a normal SSI had a GIQLI of 105 (29-140) (P < 0.0001). In patients with GERD the
quality of life could be normalized from preoperative reduced values of GIQLI
102 (47-140) to postoperative values of 117 (44-144). In patients with GERD and
somatoform disorders, the GIQLI was improved from preoperative GIQLI 75 (47-
111) to postoperative 95 (44-122) (P < 0.0043).
CONCLUSION
Patients with GERD and associated somatoform disorders have significantly
worse levels of quality of life. The latter patients can also benefit from
laparoscopic fundoplication, however they will not reach a normal level.
Key words: Gastroesophageal reflux disease; Antireflux surgery; Laparoscopic
fundoplication; Somatization; Gastroesophageal reflux disease symptoms
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Core tip: The current level of evidence performing antireflux surgery in patients with
overlapping symptoms such as dyspepsia, functional heartburn and/or somatoform
disorders is limited and debated in small case series. In a tertiary referral center for
foregut surgery (the largest center for antireflux surgery in Germany), we studied
patients with gastroesophageal reflux disease (GERD) regarding their symptomatic
spectrum over a period of 3 years. It was found that patients with GERD and associated
somatoform disorders have significantly worse levels of quality of life. The latter
patients can also benefit from laparoscopic fundoplication, however they will not reach a
normal level.
Citation: Fuchs HF, Babic B, Fuchs KH, Breithaupt W, Varga G, Musial F. Do patients
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The clinical presentation of gastroesophageal reflux disease (GERD) shows a large
variety of symptoms also in different intensities among patients[1-3]. As several studies
have shown, there is a large overlap in the symptomatic spectrum between proven
GERD  and  other  disorders  such  as  dyspepsia,  functional  heartburn  and/or
somatoform disorders[4-10]. This makes a precise diagnosis, just based on symptoms
quite unreliable for severe therapeutic decision making such as antireflux surgery[11].
GERD can be diagnosed rather easily in patients by the presence of esophagitis during
upper  gastrointestinal  (GI)  endoscopy  and/or  evidence  of  pathologic
gastroesophageal reflux in 24h-impedance-pH-monitoring, favourably optimised by a
positive  symptom-reflux  correlation  as  expressed  by  the  symptom  association
probability (SAP > 95% significant)[3,12].
Symptom-overlapping disorders such as somatisation or a somatoform tendency
can be detected in a patient, if a given person suffers from an excessive number of
somatic  complaints,  which  cannot  be  explained  by  pathophysiologic  and/or
measurable findings[13]. A symptomatic screening test by Rief et al[13-15] can be used to
identify those patients with somatoform disorders among those with proven GERD.
Recently we have shown that GERD patients do have an overlap with somatoform
tendencies in about 20% of patients of an investigated population in a tertiary referral
center[10].  A similar portion (20%) of patients with somatoform tendencies can be
detected in a population with foregut symptoms[16].
In GERD reliable decision making in long-term therapeutic strategies focuses on the
reduction of troublesome symptoms and a dependable improvement of quality of life
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for the patients after treatment. The majority of GERD patients can be treated by
conservative medical therapy such as protonpump inhibitors (PPI), while surgical
therapy should be reserved for patients with severe and progressive disease, such as
patients with anatomical and functional defects, substantial mucosal damage and/or
increasingly reduced quality of life[12,17-20]. The results of antireflux surgery are well
known and a good outcome ranges around 85%-90% in patients with proven GERD[12].
However, little is known about the success of antireflux surgery in patients with an
overlapping problem of somatoform symptoms. The question emerges, whether it is
justified to operate these patients with a combined problem of proven GERD and
somatoform tendencies and if patients with a combination of GERD and somatoform
problems would benefit from surgical therapy.
There are many reports on the outcome of laparoscopic antireflux surgery in GERD
patients, but only few reports focusing on patients with associated and overlapping
disorders such as depression or somatoform tendencies[12,17-20].  Especially data are
lacking on pre- and postoperative quality of life in patients with GERD and combined
somatoform disorders. As a consequence we performed a prospective evaluation of
patients with GERD with and without a combination of somatoform disorders before
and after laparoscopic antireflux surgery regarding their outcome.
MATERIALS AND METHODS
Methods
In a tertiary referral center for foregut surgery over a period of 3 years patients with
GERD,  qualifying  for  the  indication  of  laparoscopic  antireflux  surgery,  were
investigated prospectively regarding their symptomatic spectrum in order to identify
GERD and associated somatoform disorders. Patients, fulfilling the criteria for the
indication for laparoscopic antireflux surgery, entered the protocol and were followed
pre-, intra- and postoperatively. This allowed for the analysis of outcome parameters
between patients with GERD with and without a combined problem of somatoform
tendencies.
Patients
All patients with foregut symptoms such as heartburn who were suspicious for GERD
and referred to our specialized referral center for GI functional disease over a time
frame of 3 years were asked for their permission and registered in this present study
after  Institutional  Review  Board  approval.  This  was  followed  by  a  prospective
protocol of investigations, assessments and therapy as well as follow up assessments.
Patients fulfilling the indication criteria based on the guidelines were informed and an
indication for laparoscopic antireflux surgery was established. In patients with minor
and /or non-progressive disease, a continuation of PPI-therapy was suggested.
Diagnostic work-up
Standardized questionnaires were used to assess all presenting symptoms, and all
patients underwent a validated screening test to assess somatoform disorders and
quality of life[10,15,21]. Medical history, physical exams, upper GI endoscopy, GI function
testing (esophageal manometry and 24 h-pH-monitoring) were performed in order to
determine the presence and severity of GERD. The severity of esophagitis was graded
according to the classification of Savary-Miller or the Los Angeles Classification and
the vertical extension of a hiatal hernia was recorded. Water perfusion esophageal
manometry, later High Resolution Manometry was performed. Position, length, and
pressure of the lower esophageal sphincter were determined with the pull-through
manometry.  pH-monitoring or  later  Impedance-pH-monitoring were performed
using the DeMeester-reflux-score[1].  A a value of 14.7 was used as the borderline.
Medication affecting motility and acid suppression was stopped one week prior to
testing.
A symptom evaluation to identify somatoform disorders was performed according
to Rief et al[13-15]. As a marker for the high probability for the presence of a somatoform
tendency or disorder the somatoform symptom index (SSI) was used, as recently
described[10]. The SSI is positive for the presence of a somatoform tendency, if a given
patient has more than 17 different symptoms, of which no explanation or cause can be
detected.
Quality  of  life  was evaluated in this  study population by the Gastrointestinal
Quality of Life Index (GIQLI), which is a well established instrument and validated in
several languages[21].  The GIQLI carries 5 different components or dimensions of
quality of life such as GI-symptoms, emotional factors, physical factors, social factors
and influences by the administered therapy with a maximum index point of 144,
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evaluated by 36 questions.
Surgical procedure
Therapeutic decision making, especially the indication for laparoscopic antireflux
surgery  was  based  on  the  current  guidelines[12].  Patients  with  progressive  and
advanced disease, usually with evidence of past or present esophagitis, hiatal hernia,
incompetence of the lower esophageal sphincter, pathologic esophageal acid exposure
and/or good PPI response, preferably a PPI dosage increase over the past years as
well as a reduction in quality of Life were selected for surgical therapy. Patients with
lacking  positive  criteria  were  suggested  to  continue  their  conservative  medical
therapy and change of life style.
Patients  with indication for  surgery had to  sign an informed consent  prior  to
surgery.  Standard laparoscopic  antireflux  procedure  was  a  short  floppy Nissen
fundoplication  and  a  posterior  hiatoplasty.  In  patients  with  severe  esophageal
motility disorder usually with less than 50% of effective esophageal peristalsis left,
received a laparoscopic partial posterior Toupet hemifundoplication, also combined
with a posterior hiatoplasty and gastropexy.
The standard procedure was started with the insertion of a Verres-needle to create
a capnoperitoneum and after safety tests to access the abdominal cavity with a 10 mm
camera port. Additional 4 trocars were placed and the procedure was started with a
limited mobilisation of cranial gastric fundus especially the posterior part to create a
floppy mobile fundus with a posterior and an anterior fundic flap. In addition the
hiatus was dissected and subsequently the distal esophagus was mobilized in order to
gain a tension free esophageal segment of about 3cm of lower esophageal sphincter
within the abdominal cavity below the hiatal arch. Then the obligatory posterior hiatal
narrowing with 1-3 “figure-of-8” stitches were performed to adapt the narrowing
according to the diameter of the esophagus. Afterwards the Nissen fundoplication
was shaped around the esophageal sphincter, calibrated by a 18 mm bougie, and
sutured  including  the  esophageal  wall.  Care  was  taken  to  shape  the  wrap
symmetrically regarding the posterior and anterior fundic flap, fixing it to the right
lateral wall of the distal esophagus. Care was also taken to identify both vagal truncs
and avoid damage.
Postoperatively the patients followed some dietary restrictions starting with fluid
postop day 1 and 2, and increasing to semisolid on day 3, followed by their dismissal
with the suggestion of several small meal rather than one main meal for 4-8 wk and
refrain  from hard physical  work for  8  wk.  Postoperative  follow-up consisted of
questionaires  after  12  mo  and  a  suggestion  for  endoscopic  and  functional
investigations. The same instruments were used as prior to surgery. Patients were
separately  followed  and  analysed  depending  on  their  choice  of  therapy.  As  a
consequence, 2 groups were established: Group A post-surgical therapy; Group B:
Surgery suggested, medical therapy performed.
Statistical analysis
All data were recorded and stored in an Excel file for later comparison. The results of
the different groups were compared using the non-parametric test for paired samples
with Wilcoxon matched pairs signed rank test and the t-test for paired samples. For
comparison of quality-of-life data the Wilcoxon Two Sample test was used, since the
samples had different sizes.
RESULTS
Patients
A total of 166 patients with foregut symptoms and heartburn were prospectively
included in this study over 3 years. Mean age was 58 years (20-82) and there were 82
females.  In  123  patients  an  indication  for  laparoscopic  antireflux  surgery  was
established and in 43 patients further medical therapy was suggested, based on the
indication criteria of the EAES guidelines. Almost a third of the patients had some
kind of concomitant disease and some risk factors. The duration since the onset of the
symptoms  was  median  5  years  (1-50).  The  most  frequent  chief  complaint  was
heartburn (61%), followed by regurgitation (18%) and epigastric pain (15%). The
previous response to medication was very limited in the recent months, which led to
the referral of the patients to surgery. Esophagitis was visible on endoscopy in 51% of
the patients. Hiatal hernia was documented in 78%. Esophageal manometry showed
in 86% an incompetent lower esophageal sphincter and in 16% an ineffective motility
of the esophageal body. A pathologic esophageal acid exposure was documented in
88% of the patients.
WJG https://www.wjgnet.com January 21, 2019 Volume 25 Issue 3
Fuchs HF et al. GERD and somatoform disorders
391
After information about the disease and the operative procedure, finally 93 patients
(Group A) agreed to undergo a laparoscopic antireflux procedure. Thirty patients
decided  to  continue  medical  therapy  despite  the  fact  that  an  indication  for
laparoscopic antireflux surgery was suggested (Group B). The portion of somatoform
tendencies in the total patient population was 20.48% (34 patients), when the SSI ≥ 17
symptoms was used as criterion for the presence of somatoform disorders. In Group
A (patients with laparoscopic fundoplication) 22% (20 patients) showed a positive SSI
for somatoform tendencies, while in Group B this portion was quite similar with 20%
(6 patients) (Figure 1).
Figure 2 shows the preoperative level of the GIQLI in patients with and without a
somatoform disorder as measured by the SSI (normal < 17 symptoms). Patients with a
positive SSI (number of present symptoms ≥ 17) had a preoperative GIQLI of 77 (32-
111). Patients with a normal SSI (< 17 symptoms) had a GIQLI of 105 (29-140). This
difference was highly significant (P < 0.0001).
In  all  surgical  cases  the  primary  laparoscopic  procedure  could  be  performed
without conversion. In four patients intraoperative opening of the pleural cavity on
the left  side occurred during mobilisation of  the esophagus in the mediastinum,
resulting in a compression of the lung by gas-insufflation.  Two patients showed
postoperative minor complications such as 1 patient with an extraordinary pain level,
which  needed  3  d  of  extra  hospitalisation  as  well  as  1  patient  with  abdominal
distension and pain due to postoperative delayed intestinal motility recovery, which
also  needed  prolonged  hospital  stay.  All  patients  had  dysphagia  in  the  first  4
postoperative days during their  hospitalisation and a stepwise increase in fluid,
semisolid and finally solid food was given during this period in order to prevent
excessive gagging and vomiting, which could cause early migration.
Follow-up
After  minimum  of  1  year  follow-up  time  all  patients  were  contacted  and
questionnaires  were  returned  from  138  out  of  166  patients,  that  were  initially
investigated.  From the initially  93  patients  with laparoscopic  fundoplication,  77
patients responded and follow-up information could be obtained. Twenty-five out of
30 patients responded, who had been suggested for surgery, but decided to continue
conservative treatment. Preoperative and postoperative quality of life as assessed by
the  GIQLI  showed  a  significant  difference  (P  <  0.001)  for  patients  in  Group  A,
operated upon with laparoscopic antireflux procedure (Figure 3).
The GIQLI of the operated patients, who responded to the follow-up, was elevated
from a preoperative level of 99 (47-140) up to postoperative 117 (44-144) (P < 0.001).
The normal level of GIQLI of healthy individuals is reported from 120 to 131. Patients
with GERD, who decided to continue with conservative medical therapy despite the
suggestion for laparoscopic surgery (group B), show after the follow-up time of at
least 1 year a constant level of reduced quality of life with GIQLI of 98 (51-130; P =
0.8279; Figure 3). Within group B quality of life in those patients without somatoform
tendency (SSI < 17) had an initial GIQLI of 102, which was documented at 1 year
follow-up at 104 (not significant). Patients with a SSI > 17 had an initial GIQLI of 73,
which was 1 year later at 72. Thus medical therapy did not change the level of Quality
of life in this cohort.
Figure 4  demonstrates  the main finding of  the study,  comparing the pre-  and
postoperative level of the GIQLI, related to the presence of a somatoform disorder. In
both groups,  patients  with  GERD alone and patients  with  GERD and combined
somatoform disorder,  the  quality  of  life  could  be  significantly  increased by  the
laparoscopic antireflux procedure. In the operated patients with GERD alone, Quality
of Life could be normalized from preoperative reduced values of GIQLI 102 (47-140)
to  postoperative  values  of  117  (44-144).  In  patients  with  GERD  and  combined
somatoform disorders, the GIQLI was improved from preoperative GIQLI 75 (47-111)
to postoperative 95 (44-122) (P < 0.0043).
In summary, quality of life in patients with GERD as selected for surgery using the
criteria as published in the guidelines is severely reduced and can be elevated by
laparoscopic fundoplication to normal levels. Patients with GERD and associated
somatoform disorders have significantly worse levels of quality of life. The latter
patients can also benefit from laparoscopic fundoplication, however they will not
reach a normal level due to the large amount of present symptoms, which can not all
be influenced by antireflux surgery.
DISCUSSION
It has been shown that the classic clinical presentation of the GERD has a remarkable
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Figure 1
Figure 1  Incidence of somatoform symptoms in patients with gastroesophageal reflux disease. Group A:
patients with indication for surgery, willing to undergo surgery. The percentage of SSI ≥ 17 was 22%; Group B:
Patients with GERD and indication for surgery, who has refused antireflux surgery and have continued protonpump
inhibitors therapy. The percentage of SSI ≥ 17 was 20%. GERD: Gastroesophageal reflux disease; SSI: Somatoform
Symptom Index.
symptom  overlap  with  other  often  functional  disorders  such  as  heartburn,
somatization and/or hypertensive esophagus and others[3-10]. Several instruments have
been used in the past to assess the presence of such conditions in order to verify the
precise  diagnosis  and  document  the  combination  of  GERD  with  somatoform
tendencies[4-10,13-15]. Recently the relationship between GERD and somatoform disorders
was published demonstrating a 20% incidence of combined somatoform tendencies in
a population of GERD patients with more than 17 symptoms present[10]. This confirms
early reports of similar involvement of patients with both conditions[16]. Two questions
emerge  whether  a  patient  with  somatoform  disorder  can  be  detected  within  a
population of GERD-patients and secondly, if these patients should be selected for
antireflux surgery.
Somatization represents a situation where somatic complaints cannot be explained
by measurable findings[10,15]. Psychodiagnostic instruments are necessary to clarify the
situation  and establish  an  objective  diagnosis.  A variety  of  tests  can  be  used to
evaluate persons with the suspicion of a somatoform tendency[10,13,15,22-24]. Often these
patients may have depression and anxiety, which can influence the clinical assessment
of patients[23-25]. The basis for an optimal selection of patients with GERD for surgery is
a  comprehensive  diagnostic  work-up  to  generate  evidence  for  an  advanced,
progressive disease with proven damage and functional defects.
Besides a good surgical technique, the optimal selection of the right patients for
laparoscopic fundoplication is of utmost importance for the final result of surgical
therapy. Laparoscopic fundoplication can produce an ideal solution for a patient with
severe and progressive GERD, reducing most of  the troublesome symptoms and
enabling the patient to live a normal joyful life[12]. Having expressed this, it must be
emphasized that performing a fundoplication on the wrong patient, who either does
not need a fundoplication or who has other problems, which could be worsened by a
fundoplication, can easily destroy the patient`s quality of life.
Patients with somatoform disorders usually have a large variety of symptoms,
where typical reflux symptoms such as heartburn and acid regurgitation may play
only a limited role or may be overrated by the patient due to the stress and heavy load
of all symptoms. In these cases the question emerges, whether surgery is justified.
Objective diagnostic testing is essential to verify pathologic gastroesophageal reflux,
but still given the tests are positive, there is still a dilemma, whether patients would
benefit  from  antireflux  surgery.  Some  surgeons  advise  to  see  these  patients  as
contraindications for antireflux surgery[17,18].
Little is known about the probability of success after surgical therapy in these
patients with the combined problem. Therefore the present study shows very clearly
that  a  precise  diagnostic  work-up  is  necessary  to  determine  the  presence  of  a
somatoform tendency as well as the presence of severe GERD. The study is helpful in
showing evidence that on one hand improvement of quality of life is possible, and on
the other hand that quality of life can rather not be normalized, since too many other
symptoms are involved with no connection the underlying reflux problem.
The problem is that patients with GERD and somatoform disorders start from a
preoperative significantly lower level of quality of life than GERD patients without
somatoform tendencies.  Interesting  enough laparoscopic  antireflux  surgery  can
elevate the GIQLI for about 20-25 points in patients.  The latter  causes in GERD-
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Figure 2
Figure 2  Preoperative quality of life, as measured by the Gastrointestinal Quality of Life Index in patients
with gastroesophageal reflux disease alone (median GIQLI: 105) and patients with gastroesophageal reflux
disease and associated somatoform tendencies (SSI ≥ 17) (median GIQLI: 77). This difference is significant (P <
0.001). SSI: Somatoform Symptom Index; GIQLI: Gastrointestinal Quality of Life Index; GERD: Gastroesophageal
reflux disease.
patients without associated problems a postoperative quality of life level of nearly
normal levels while patients with both, GERD and somatisation will usually remain in
a lower level, which can cause postoperative disappointment and frustration. This
should  be  communicated  to  the  patients  prior  to  surgery  to  make  sure  that  the
preoperative expectations will not be unrealistic.
In conclusion, patients with GERD and overlapping symptoms due to somatoform
disorders should not be withhold from laparoscopic antireflux surgery in general, if
their GERD is proven by objective assessment. It must be however emphasized that
these patients must be especially informed about their critical situation regarding
their large number of often atypical symptoms, which cannot be cured completely.
The latter causes continuing restrictions in their quality of life. As a consequence the
indication for antireflux surgery must be discussed in detail with the patients and
only those should be selected, in whom reflux-generated-symptoms are proven by
reflux symptom-correlation[26]. These symptoms should be the major quality-of-life
restricting factors.
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Figure 3
Figure 3  Pre-and post-therapeutic quality of life, as measured by the Gastrointestinal Quality of Life Index, for both groups. Group A after laparoscopic
antireflux surgery (GIQLI preop: 91; postop 117; P < 0,001) and Group B after continued conservative treatment (GIQLI pre: 96; post: 98; P = 0.8279). In the surgical
group, GIQLI could be significantly increased. GIQLI: Gastrointestinal Quality of Life Index.
Figure 4
Figure 4  Comparison of pre- and postoperative levels of Gastrointestinal Quality of Life Index in relation to the presence of somatoform disorders. Patients
with somatoform disorders will also improve their GIQLI postoperatively (GIQLI preop: 75; postop: 95; P < 0.0043), however it could not be increased to normal levels
due to the large number of non-related symptoms. Patients with SSI < 17 could reach normal levels of GIQLI postoperatively (preop: 102; postop: 117; P < 0.001).
GIQLI: Gastrointestinal Quality of Life Index; SSI: Somatoform Symptom Index; GERD: Gastroesophageal reflux disease.
ARTICLE HIGHLIGHTS
Research background
Gastroesophageal reflux disease (GERD) shows a large symptom variation also in different
intensities among patients. Up-to-date, patients with somatoform tendencies were often per se
excluded from surgery.
Research motivation
There is a large overlap in the symptomatic spectrum between GERD and other disorders such
as dyspepsia, functional heartburn or somatoform disorders. We intended to be able to better
differentiate between these different entities to provide optimal patient care. Before our study, it
was still unclear if patients with somatoform tendencies should undergo surgery at all.
Research objectives
The purpose of this study is an evaluation of patients with GERD with and without somatoform
disorders before and after laparoscopic antireflux surgery regarding their outcome.
Research methods
In the largest center for benign foregut surgery in Germany patients with GERD, qualifying for
antireflux surgery were investigated prospectively regarding their symptomatic spectrum in
order to identify GERD and associated somatoform disorders over a period of 3 years using an
instrument  for  the  evaluation  of  somatoform  disorders.  Quality  of  life  was  evaluated  by
Gastrointestinal Quality of Life Index (GIQLI). These parameters were compared depending on
the group assignment of patients.
Research results
One fifth of all included patients suffered from somatoform tendencies (20.48%; 34 patients).
Patients  with this  tendency had a preoperative GIQLI of  77 (32-111).  Patients  without this
WJG https://www.wjgnet.com January 21, 2019 Volume 25 Issue 3
Fuchs HF et al. GERD and somatoform disorders
395
tendency had a GIQLI of 105 (29-140; P  < 0.0001). Quality of life could be normalized from
preoperative reduced values of GIQLI 102 (47-140) to postoperative values of 117 (44-144) in
patients with GERD. GIQLI of patients with GERD and somatoform tendency was improved
from preoperative GIQLI 75 (47-111) to postoperative 95 (44-122; P < 0.0043).
Research conclusions
This is the first study to show that patients with a somatoform tendency should not be excluded
from surgery, however they will not reach a normal level of quality of life. Patients with GERD
and somatoform disorders have an impaired quality of life. The latter patients can also benefit
from laparoscopic fundoplication, however they will not reach a normal level.
Research perspectives
The investigated instruments for assessment of quality of life and somatoform disorders can help
to discriminate between the different symptom origins and should be used in all patients who
undergo antireflux surgery.
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